Polyscore of autonomic parameters for risk stratification of the elderly general population: the Polyscore study.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
21 05 2021
Historique:
received: 19 07 2020
accepted: 09 11 2020
pubmed: 5 12 2020
medline: 10 8 2021
entrez: 4 12 2020
Statut: ppublish

Résumé

Present society is constantly ageing and elderly frequently suffer from conditions that are difficult and/or costly to treat if detected late. Effective screening of the elderly is therefore needed so that those requiring detailed clinical work-up are identified early. We present a prospective validation of a screening strategy based on a Polyscore of seven predominantly autonomic, non-invasive risk markers. Within a population-based survey in Germany (INVADE study), participants aged ≥60 years were enrolled between August 2013 and February 2015. Seven prospectively defined Polyscore components were obtained during 30-min continuous recordings of electrocardiogram, blood pressure, and respiration. Out of 1956 subjects, 168 were excluded due to atrial fibrillation, implanted pacemaker, or unsuitable recordings. All-cause mortality over a median 4-year follow-up was prospectively defined as the primary endpoint. The Polyscore divided the investigated population (n = 1788, median age: 72 years, females: 58%) into three predefined groups with low (n = 1405, 78.6%), intermediate (n = 326, 18.2%), and high risk (n = 57, 3.2%). During the follow-up, 82 (4.6%) participants died. Mortality in the Polyscore-defined risk groups was 3.4%, 7.4%, and 17.5%, respectively (P < 0.0001). The Polyscore-based mortality prediction was independent of Framingham score, diabetes, chronic kidney disease, and major stroke and/or myocardial infarction history. It was particularly effective in those aged <75 years (n = 1145). The Polyscore-based mortality risk assessment from short-term non-invasive recordings is effective in the elderly general population, especially those aged 60-74 years. Implementation of a comprehensive Polyscore screening of this age group is proposed to advance preventive medical care.

Identifiants

pubmed: 33276379
pii: 6024429
doi: 10.1093/europace/euaa359
pmc: PMC8139819
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-796

Subventions

Organisme : British Heart Foundation
ID : NH/16/2/32499
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
JAMA. 2017 Nov 7;318(17):1668-1678
pubmed: 29114831
BMC Fam Pract. 2013 Jan 22;14:13
pubmed: 23339773
Circulation. 1991 Jan;83(1):356-62
pubmed: 1984895
Eur Heart J. 2014 Jul 1;35(25):1642-51
pubmed: 24801071
Front Physiol. 2019 Feb 04;10:49
pubmed: 30778303
BMJ. 2012 Jun 21;344:e4181
pubmed: 22723603
Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1863-6
pubmed: 8945057
J Am Heart Assoc. 2018 Jan 6;7(1):
pubmed: 29306895
Diabetes Care. 2011 Aug;34(8):1833-7
pubmed: 21680727
Curr Pharm Des. 2016;22(25):3817-28
pubmed: 26965489
J Am Heart Assoc. 2014 Jun 03;3(3):e000857
pubmed: 24895163
Eur Heart J. 2013 Jun;34(22):1644-50
pubmed: 23242188
J Am Coll Cardiol. 2016 May 17;67(19):2213-2220
pubmed: 27173032
Heart Rhythm. 2012 Aug;9(8):1288-94
pubmed: 22516186
Nervenarzt. 2002 Dec;73(12):1199-204
pubmed: 12486573
J Physiol. 2019 May;597(10):2595-2598
pubmed: 31006862
Lancet. 2006 May 20;367(9523):1674-81
pubmed: 16714188
Europace. 2016 Jun;18(6):925-44
pubmed: 26823389
Lancet. 1999 Apr 24;353(9162):1390-6
pubmed: 10227219

Auteurs

Alexander Steger (A)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Michael Dommasch (M)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Alexander Müller (A)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Daniel Sinnecker (D)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Katharina M Huster (KM)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Teresa Gotzler (T)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Othmar Gotzler (O)

INVADE Study Group, Karl-Böhm-Str. 32, 85598 Baldham, Germany.

Alexander Hapfelmeier (A)

Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München, Grillparzerstr. 18, 81675 Munich, Germany.

Kurt Ulm (K)

Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München, Grillparzerstr. 18, 81675 Munich, Germany.

Petra Barthel (P)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Katerina Hnatkova (K)

National Heart and Lung Institute, Imperial College, ICTEM, Hammersmith Campus, 72 Du Cane Road, Shepherd's Bush, London W120NN, UK.

Karl-Ludwig Laugwitz (KL)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Marek Malik (M)

National Heart and Lung Institute, Imperial College, ICTEM, Hammersmith Campus, 72 Du Cane Road, Shepherd's Bush, London W120NN, UK.
Department of Internal Cardiology Medicine, Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00 Brno, Czech Republic.

Georg Schmidt (G)

Klinik für Innere Medizin I, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH